CompletedNot Applicable

Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

Egypt40 participantsStarted 2024-11-14

Plain-language summary

This study aims to evaluate the role of dexmedetomidine as an adjuvant in external oblique intercostal plane block for post-thoracotomy pain.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-III. * Scheduled for open thoracotomy. Exclusion Criteria: * Patients with neurological or intellectual disability. * Infection at the injection site. * Drug abuse. * Allergic reaction to local anesthetics. * Coagulation abnormalities. * Pregnancy. * Body Mass Index (BMI) ≥35 kg/m2. * Severe cardiovascular problems. * Diabetic neuropathy.

What they're measuring

Time to the 1st rescue analgesia

Timeframe: 48 hours postoperatively

Trial details

NCT IDNCT06684535

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-07

View on ClinicalTrials.gov More Dexmedetomidine trials